Association between serum visfatin levels and psoriasis and their correlation with disease severity: a meta-analysis
Open Access
- 26 March 2021
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (3)
Abstract
To determine the association between serum visfatin levels and psoriasis and to evaluate the correlation between serum visfatin levels and the severity of psoriasis. The electronic databases PubMed®, Embase® and the Cochrane Library were searched for articles published from inception to 1 May 2020. Data were extracted and then standard mean differences (SMDs) and 95% confidence intervals (CIs) were calculated for pooled estimates. A total of 11 studies met the inclusion criteria and were included (448 patients diagnosed with psoriasis and 377 controls). This meta-analysis demonstrated that patients with psoriasis had significantly higher levels of visfatin than the controls (SMD = 0.90, 95% CI 0.52, 1.28). Subgroup analyses showed that differences in serum visfatin levels between the patient group and the control group were associated with ethnicity, Psoriasis Area and Severity Index (PASI) and body mass index. Additionally, a meta-analysis of correlations showed that visfatin levels in patients with psoriasis were positively correlated with PASI (r = 0.51, 95% CI 0.14, 0.75). This meta-analysis showed that serum visfatin levels in patients with psoriasis were significantly higher than those in the controls and a positive correlation between serum visfatin levels and psoriasis severity was observed.Keywords
Funding Information
- Construction of Talent Platform Project of Ningxia (NXKJT2019012)
- Key Research and Development project of Ningxia (2019BFG02008)
This publication has 44 references indexed in Scilit:
- Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohortBritish Journal of Dermatology, 2013
- Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic reviewDiabetes/Metabolism Research and Reviews, 2011
- Prevalence of the Metabolic Syndrome in PsoriasisArchives of Dermatology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- UCP1: its involvement and utility in obesityInternational Journal of Obesity, 2008
- Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesisCardiovascular Research, 2007
- RetractionScience, 2007
- Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzymeNature Structural & Molecular Biology, 2006
- Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of InsulinScience, 2005
- SKIN DISEASE AND SOCIOECONOMIC CONDITIONS IN RURAL AFRICA: TANZANIAInternational Journal of Dermatology, 1996